T45.694
Poisoning by other fibrinolysis-affecting drugs, undetermined
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by fibrinolysis-affecting drugs involves exposure to medications that influence the body's process of breaking down blood clots. These drugs play an important role in treating certain medical conditions but can cause adverse effects if misused or accidentally ingested. The ICD-10 code T45.694 categorizes cases where the poisoning is due to other fibrinolysis-affecting drugs, with the specific source or cause undetermined. Understanding this condition can help in recognizing potential risks and the importance of proper medication management.
Causes & Symptoms
Clinical Causes: Accidental ingestion of fibrinolysis-affecting medications, especially in children Incorrect dosage administration, either too high or too frequent Medication errors during prescribing or dispensing Use of fibrinolytic drugs outside medical supervision, such as self-medicating Exposure to counterfeit or contaminated medications containing fibrinolytic agents Intentional poisoning or self-harm using these medications
Key Symptoms: Unusual bleeding or hemorrhages, such as bruises, nosebleeds, or blood in stool or urine Excessive bleeding from cuts or injuries Internal bleeding manifesting as pain, swelling, or tenderness Signs of anemia, including fatigue, weakness, and pale skin Possible allergic reactions, like rash, itching, or swelling
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history review, identifying recent exposure or ingestion of fibrinolytic medications, and laboratory tests. These tests may include blood clotting studies, complete blood count (CBC), and specific assays to measure drug levels or activity. Medical professionals may also evaluate for signs of bleeding complications or other adverse effects associated with fibrinolytic agents.
Treatment Protocols: Treatment focuses on managing bleeding complications and stopping further exposure to the offending agent. This may include administering medications to counteract excessive bleeding, providing supportive care such as blood transfusions, and close monitoring of vital signs and laboratory parameters. In certain cases, specific antidotes or reversal agents may be utilized if available. While some cases resolve with supportive care, severe poisoning requires hospitalization and specialized medical intervention.
Clinical Advice & FAQs
Billing Guidance
Is T45.694 a billable ICD-10 code?
Yes, T45.694 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.694?
Clinical documentation must specify the nature of Poisoning by other fibrinolysis-affecting drugs, undetermined and any associated comorbidities for accurate reporting.
Cite this Clinical Reference